<DOC>
	<DOC>NCT01983215</DOC>
	<brief_summary>The purpose of the study is to determine the effects of Prevena therapy on decreasing groin surgical site infections in patients who are obese and /or diabetic having vascular surgery.</brief_summary>
	<brief_title>Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites</brief_title>
	<detailed_description>Patients who are obese and/or diabetic may have poor surgical healing and infection rates higher. The PREVENA therapy will be used to evaluate possible reduction of infection rates in this patient population</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>subjects over 18 years old obese (BMI &gt; 30) and or diabetic current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>groin incisions</keyword>
</DOC>